SMAD3 and neoplasm: In vitro analyses have shown a tumor suppressor role of miR-145, where miR-145 inhibits TGF-β-induced epithelial-mesenchymal transition and invasion through the repression of SMAD3 and TGFBR2 in NSCLC cells [60, 61].